When migraine progresses: transformed or chronic migraine

References

• Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA 28(291), 493–494 (2004).
   Google Scholar
• Lipton RB, Goadsby P, Silberstein SD. Classification and epidemiology of headache. Clin. Cornerstone 1(6), 1–10 (1999).
   PubMedGoogle Scholar
• Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 27, 102–106 (1987).
   PubMed Web of Science ®Google Scholar
• Scher AI, Stewart WF, Liberman J et al. Prevalence of frequent headache in a population sample. Headache 38, 497–506 (1998).
   PubMed Web of Science ®Google Scholar
• Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 38, 497–506 (1999).
   Google Scholar
• Spierings ELH, Ranke AH, Schroevers M, Honkoop PC. Chronic daily headache: a time perspective. Headache 40, 306–310 (2000).
   PubMedGoogle Scholar
• Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 43(4), 336–342 (2003).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 8(Suppl. 7), 1–96 (1988).
   Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Second Edition. Cephalalgia (Suppl. 1), 1–160 (2004).
   Google Scholar
• Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47, 871–875 (1996).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 44(7), 684–691 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Dodick D, Lipton RB et al. Classifying migraine patients with primary chronic daily headache consensus statement from the American Headache Society. Headache (In Press) (2006).
   Google Scholar
• Hagen K, Zwart JA, Vatten L, Stovner LJ, Bovim G. Prevalence of migraine and non-migrainous headache-head-HUNT, a large population-based study. Cephalalgia 20(10), 900–906 (2000).
   PubMed Web of Science ®Google Scholar
• Dowson AJ, Dodick DW, Limmroth V. Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 19(6), 483–497 (2005).
   PubMedGoogle Scholar
• Mathew NT. Transformed migraine. Cephalalgia 13(Suppl. 12), 78–83 (1993).
   PubMedGoogle Scholar
• Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB. The classification of chronic daily headache in adolescents – a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 45(5), 582 (2005).
   PubMedGoogle Scholar
• Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB. Migraine days decline with duration of illness in adolescents with transformed migraine. Cephalalgia 25(7), 482–487 (2005).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 63(5), 843–847 (2004).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic migraine is the early stage of transformed migraine. Neurology 65(10), 1556–1561 (2005).
   Google Scholar
• Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41, 629–637 (2001).
   PubMed Web of Science ®Google Scholar
• Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA 291, 427–434 (2004).
   PubMed Web of Science ®Google Scholar
• Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 63(11), 2022–2027 (2004).
   PubMed Web of Science ®Google Scholar
• Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1–2), 81–89 (2003).
   PubMed Web of Science ®Google Scholar
• Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology 60(8), 1366–1368 (2003).
   PubMedGoogle Scholar
• Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann. Neurol. 55, 27–36 (2004).
   PubMed Web of Science ®Google Scholar
• Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol. 47, 614–624 (2000).
   PubMed Web of Science ®Google Scholar
• Bigal M, Liberman J, Lipton RB. Migraine and obesity, a population study. Neurology 66(4), 545–550 (2006)
   PubMed Web of Science ®Google Scholar
• Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache. Headache 42(6), 543–547 (2002).
   PubMed Web of Science ®Google Scholar
• Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 62(9), 1540–1544 (2004).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME. Chronic daily headache: is analgesic overuse a cause or a consequence? Neurology 61(2), 154–155 (2003).
   PubMed Web of Science ®Google Scholar
• Silverman K, Evans SM, Strain EC et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N. Engl. J. Med. 327, 1109–1114 (1992).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 24(6), 483–490 (2004).
   PubMed Web of Science ®Google Scholar
• Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41(3), 303–309 (2001).
   PubMed Web of Science ®Google Scholar
• Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43(3), 179–190 (2003).
   PubMed Web of Science ®Google Scholar
• Relja G, Granato A, Maria Antonello R, Zorzon M. Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache. Headache 44(2), 148–153 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Chronic daily headache. J. Am. Osteopath. Assoc. 105(4 Suppl. 2), 23S–29S (2005).
   Google Scholar
• Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology 66(2), 193–197 (2006).
   Google Scholar
• Holroyd KA, Penzien DB, Lipchik GL. Behavioral management of headache. In: Wolff´s Headache and other Head Pain. Silberstein SD, Lipton RB, Dalessio DJ (Eds) Oxford University Press, NY, USA, 562–598 (2001).
   Google Scholar
• Holroyd KA, Andrasik F. A cognitive-behavioral approach to recurrent tension and migraine headache. In Advances in Cognitive-Behavioral Research and Therapy. Kendall PE (Ed.). Academic Press, NY, USA (1982).
   Google Scholar
• Weeks R. The difficult headache patient calls for a multifaceted approach. Neurol. Rev. 3, 15–16 (1995).
   Google Scholar
• Grazzi L, Andrasik F, D’Amico D et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42, 483–490 (2002).
   PubMed Web of Science ®Google Scholar
• Diener HC, Haab H, Peters C et al. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31, 205–209 (1991).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre – clinical characteristics and treatment outcomes. Cephalalgia 24(6), 483–490 (2004).
   PubMed Web of Science ®Google Scholar
• Bonuccelli U, Nuti A, Lucetti C et al. Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 16, 197–200 (1996).
   Google Scholar
• Drucker P, Tepper S. Daily sumatriptan for detoxification from rebound. Headache 38, 687–690 (1998).
   PubMedGoogle Scholar
• Krymchantowski AV. Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug consumption. Arq. Neuropsiquiatr. 61, 43–47 (2003).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Asgharnejad M, Peykamian M, Laurenza A. Naratriptan is effective and well-tolerated in the acute treatment of migraine: results of a double-blind, placebo-controlled, crossover study. Neurology 49, 1485–1490 (1997).
   PubMed Web of Science ®Google Scholar
• Sheftell FD, Rapoport AM, Coddon DR. Naratriptan in the prophylaxis of transformed migraine. Headache 39, 506–510 (1999).
   PubMedGoogle Scholar
• Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 36, 995–997 (1986).
   PubMed Web of Science ®Google Scholar
• Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: Chronic daily headache and migraine. Headache 34, 497–502 (1994).
   PubMed Web of Science ®Google Scholar
• Saper JR, Lake AE, Tepper SJ. Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 41, 465–474 (2001).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 31, 71–74 (1991).
   PubMed Web of Science ®Google Scholar